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Abstract
Background: Platelet satellitism is a phenomenon of unknown etiology of aggregating platelets around polymorphonuclear neutrophils and other 
blood cells which causes pseudothrombocytopenia, visible by microscopic examination of blood smears. It has been observed so far in about a hun-
dred cases in the world.
Case subject and methods: Our case involves a 73-year-old female patient with a urinary infection. Biochemical serum analysis (CRP, glucose, 
AST, ALT, ALP, GGT, bilirubin, sodium, potassium, chloride, urea, creatinine) and blood cell count were performed with standard methods on autoa-
nalyzers. Serum protein fractions were examined by electrophoresis and urinalysis with standard methods on autoanalyzer together with microsco-
pic examination of urine sediment. Erythrocyte sedimentation rate, blood culture and urine culture tests were performed with standard methods.
Results: Due to typical pathological values for bacterial urinary infection, the patient was admitted to the hospital. Blood smear examination reve-
aled phenomenon, which has persisted for three weeks after the disease has been cured. Blood smears with EDTA as an anticoagulant had platelet 
satellitism whereas the phenomenon was not observed in tubes with different anticoagulants (Na, Li-heparin) and capillary blood.
Discussion: We hypothesize that satellitism was induced by some immunological mechanism through formation of antibodies which have media-
ted platelets binding to neutrophil membranes and vice versa. Unfortunately we were unable to determine the putative trigger for this phenome-
non. To our knowledge this is the second case of platelet satellitism ever described in Croatia.
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Case report
Background
The phenomenon of “platelet satellitism” (PS) was 
first presented by Field and McLeod in 1963, in the 
British Medical Journal (1). The phenomenon has 
been observed in 14-year-old boy with neurologi-
cal problems. Until now, this phenomenon has 
been described in about one hundred cases in 
people of different ages, suffering from various 
pathological conditions, including infectious dis-
eases (2-4), as well as in healthy individuals (5-7). 
Under the influence of ethylenediaminetetraacetic 
acid (EDTA) as an anticoagulant, the platelets have 
the ability to create formations around polymor-
phonuclear neutrophils (PMN) (mostly granulo-
cyte), monocytes and around basophilic and eo-
sinophilic granulocytes (non-lymphocitic white 
blood cells), granulated lymphocytes (8) and even 
atypical lymphocytes (9). 
In most cases, hematology analyzers recognize 
such formations as the white blood cell lineage, 
and consequently give a falsely low platelet count 
or pseudoplatelet syndrome (10). Furthermore, to 
our knowledge blood taken without the addition 
of EDTA (capillary blood) does not display the 
above in vitro phenomenon, nor venous blood 
taken with the addition of any other anticoagu-
lant, such as sodium-citrate or lithium-heparin 
(5,6,11-14). In vitro grouping of the platelets around 
polymorphonuclear neutrophils (PMNs) and other 
Biochemia Medica 2015;25(2):285–94  http://dx.doi.org/10.11613/BM.2015.030 
286
Vidranski V. et al. Platelet satellitism 
cells imparting a rosette-like appearance is a phe-
nomenon popularly called “platelet satellitism”, 
and it occurs in blood samples anticoagulated 
only with K3EDTA at room temperature. The phe-
nomenon is only partially explained so it still re-
mains a major challenge in the everyday routine 
work of specialists in laboratory medicine.
Pseudothrombocytopenia in general and as a con-
sequence of “platelet satellitism” is a widespread 
problem present in a number of diseases, and 
sometimes remains undiscovered. It is particularly 
necessary to identify it and exclude possible in vit-
ro interference. In Croatia, only one case of this 
phenomenon has been described so far, in a trau-
ma patient treated for left femur fracture. Just like 
our patient, the patient from Trauma Clinic, among 
other, suffered from a urinary tract infection (15).
Our case involves patient with a urinary infection, 
in whom platelet satellitism persisted even after 
the successful treatment of the disease.
To date, the phenomenon of PS has not been com-
pletely clarified with certainty, but there are hy-
potheses involving both immune and non-im-
mune mechanisms. Bizzaro et al. have presented 
evidence suggesting immunological binding of 
EDTA-dependent antiplatelet and anti-neutrophil 
IgG antibodies directly on glycoprotein complex 
IIb/IIIa of the platelet membrane as well as the Fc 
gamma receptor III (FcγRIII) of polymorphonuclear 
neutrophils, that indicates the existence of IgG an-
tibodies that directly form a connection or 
“bridge” between platelets and neutrophils. In ad-
dition, the antibody did not react with platelets 
from a patient with type I Glanzmann’s disease, 
nor with neutrophils from a patient with congeni-
tal Fc gamma RIII absence (NAnull phenotype), 
thus confirming both specificities. As in other liter-
ature cases, a clear correlation between the pres-
ence of IgG and a specific clinical situation, dis-
ease, or use of drugs could not be shown. There-
fore, these antibodies, which are present in some 
normal, healthy individuals, might occur naturally. 
Because of the exposure of particular cryptoanti-
genic structures present on EDTA-modified plate-
let and PMNs, they may manifest themselves by 
triggering the PS phenomenon (16). 
The working hypothesis of the PS phenomenon is 
that EDTA, by chelating Ca2+ ions, changes the 
platelet membrane and unmasks (crypto) antigen-
ic structures on platelet GPIIb/IIIa and PMN neu-
trophils, which are then been recognized by IgG 
enabling a formation of a “bridge” between the 
two cells. Why PS patients produce these IgG 
(auto) antibodies and what is the mechanism of 
their interaction with target molecules on platelet 
and PMN membranes, is still unclear (15).
The functions of GP IIb/IIIa in platelet physiology 
are diverse. Although most functions are manifest-
ed after platelet stimulation, there are approxi-
mately 40 000 antibody molecules bound to the 
surface of platelets, indicating that there are prob-
ably 40 000 to 80 000 GPIIb/IIIa receptors on the 
surface of one unstimulated platelet, depending 
on whether the antibodies bind bi- or mono-va-
lently. Thus, GPIIb/IIIa is probably the most dense 
adhesion/aggregation receptor present on any 
cell.
Christopoulos and Mattock suggest non-immuno-
logical process which includes linking of platelets 
via thrombospondin or some other alpha granule 
proteins such as P-selectin (11). Adhesion of plate-
lets to neutrophils is possible by existence of an 
active stimulus presented on the surface of plate-
lets (11,12,17).
According to Moreselli et al. at lower temperatures 
EDTA can accelerate the whole process by binding 
calcium ions, based on the fact that the GPIIb / IIIa 
antagonists binding depends on the calcium ions 
concentration in the plasma (6).
It is an interesting fact that kanamycin added to 
EDTA blood shows dispersion of platelets from 
neutrophils (18).
Espanol and colleagues in their study have shown 
that combination of morphologic studies of gran-
ulated lymphocytes with PS and immunopheno-
typic studies displaying CD16 positivity indicates 
that lymphocytes with natural killer cell activity 
could exhibit PS. CD16 is cell surface antigen also 
known as neutrophil antigen NA, HNA1 and has 
been identified as Fc receptors FcγRIIIa (CD16a) 
and FcγRIIIb (CD16b). These receptors bind to the 
Fc portion of IgG antibodies which then activate 
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the NK cell for antibody-dependent cell-mediated 
cytotoxicity. A lack of CD16 in a given population 
of neutrophils may indicate prematurity, as it could 
be caused by a left-shift due to neutrophilic leuko-
cytosis induced by tissue necrosis or bacterial in-
fection (9).
The aim of this report is to present a case of a 
73-year-old female patient with a urinary infection 
in whom we have observed a platelet satellitism 
which has persisted even after the disease was 
successfully treated. With this report we wish to 
contribute to the global understanding of this rare 
phenomenon by providing some new information 
and discussing the possible mechanisms. 
Case subject and methods
Case subject
A 73-year-old female patient was hospitalized at 
the University hospital for infectious diseases Dr. 
Fran Mihaljevic in Zagreb, Croatia, for a period of 
nine days, due to recurrent urinary tract infection 
(diagnosis: acute pyelonephritis, E. coli). Medical 
history revealed that the patient had suffered from 
rheumatic fever, underwent tonsillectomy, appen-
dectomy and cholecystectomy, and had chronic 
gastritis and cysts in both kidneys. She was using 
esomeprazole on a regular basis and benzodiaze-
pine and ketoprofen when necessary. The patient 
reported allergy to the following medications: An-
algin® (Pliva, Croatia) and Buscopan® (Boehringer 
Ingelheim, Germany ).
The patient was referred to the Hospital because 
of frequent, repeated urinary tract infections, 
shaking chills and current pain in the kidney area 
accompanied with frequent and painful urination.
Methods
After admission of the patient to the emergency 
room, along with the medical history, all routine 
biochemical tests were made (C-reactive protein 
(CRP), aspartate aminotransferase (AST), alanine 
aminotransferase (ALT), alkaline phosphatase 
(ALP), gamma-glutamyltransferase (GGT), biliru-
bin, sodium, potassium, chloride, urea and creati-
nine (Table 1), blood culture, urinalysis and urine 
culture (Table 2) and also complete blood count 
(CBC) and erythrocyte sedimentation rate (ESR) 
(Table 3). Control testing was done on 3rd and 9th 
day of hospital stay, as well as serum protein elec-
trophoresis test (9th day) and blood smear exami-
nation (3rd and 9th day of hospital stay and 23 
days after hospitalization).
Biochemical analysis was performed using the 
Beckman Coulter AU 640 automated chemistry 
analyzer with analytical principle of spectropho-
tometry and potentiometry, with Beckman-Coul-
ter (BC) assays (Beckman Coulter, USA), BC calibra-
tor kits and Bio-Rad Lyphochek (Bio-Rad Laborato-
ries, USA) assayed chemistry controls. Analytical 
methods were: photometry (glucose, AST, ALT, 
ALP, GGT, bilirubin, urea, and creatinine), indirect 
ISE-potentiometry (sodium, potassium and chlo-
ride) and latex agglutination (CRP). 
Urine analysis were done on Roche Urysis 1800 (re-
flectance photometry) with Combur test stripes 
(Roche Diagnostics, Switzerland), original calibra-
tors and Bio-Rad Liquichek (Bio-Rad Laboratories, 
USA) urinalysis controls. Urine for native urine sed-
iment testing was centrifuged for 10 minutes at 
395 x g and sediment was examined under the 
light microscope Olympus CH2-CHS (Olympus, 
Germany).
Concentration of total proteins and protein elec-
trophoresis were assayed on Hydrasis (Sebia, 
France) using agarose gel electrophoresis systems. 
The inter-assay CV reported by the manufacturer 
for IgG was from 2.0% to 3.4%.
Blood count was analyzed on UniCel DxH800, 
Beckman-Coulter (Beckman Coulter, USA), with 
Beckman-Coulter reagents and original controls. 
Blood smears were stained manually, using the 
May-Grunwald-Giemsa stein (Merck, Germany) 
and observed in the light microscope Olympus 
BX51, Camera Olympus SC20, Olyumpus-CMAD3 
(Olympus, Japan). Peripheral blood smears were 
prepared within 2 hours of blood collection. 
All analyses were done in fresh samples, within the 
appropriate time for analysis. We don’t have infor-
mation about fasting status of the patient for any 
of the periods during the blood analysis.
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Parameter 1st day 3rd day 9th day* Reference interval
CRP (mg/L) 195.9 157.0 13.6 <5
Glucose (mmol/L) 6.0 - - 4.4-6.4
AST (U/L) 19 - 18 8-30
ALT (U/L) 16 - 23 10-36
ALP (U/L) 54 - 63 64-153
GGT (U/L) 19 - 27 9-35
Bilirubin (µmol/L) 26.7 - 6.8 3-20
Sodium (mmol/L) 140 - - 137-146
Potassium (mmol/L) 4.5 - - 3.9-5.1
Chloride (mmol/L) 104 - - 97-108
Urea (mmol/L) 6.8 - - 2.8-8.3
Creatinine (µmol/L) 94 - - 63-107
CRP - C-reactive protein; AST - aspartate aminotransferase; ALT - alanine aminotransferase; ALP - alkaline phosphatase; GGT - gam-
ma-glutamyltransferase.
* Patient was discharged on 9th day.
Table 1. Laboratory values of biochemical parameters during hospitalization
Peripheral blood samples were collected by veni-
puncture in 3 mL and/or 6 mL Vaccuete® serum 
tubes with clot activator (red cap), hematology 
tubes (K3EDTA tubes, lavender cap), ESR tubes (so-
dium citrate 3.2%, black cap), tubes with lithium 
heparin (green cap), coagulation tubes with 3.2% 
(0.109 M) and sodium citrate (light blue cap) tubes 
(Greiner Bio-One, Kremsmünster, Austria).
After the discovery of PS, blood was analyzed in 
test tubes with sodium-citrate and lithium-hepa-
rin. Platelet count obtained from blood with the 
addition of Na-citrate, was multiplied by 1.1 to cor-
rect for sample dilution. Citrate anticoagulation re-
duces the ionized calcium concentration normally 
found in blood (19).
Blood for serum testing was centrifuged for 10 
minutes at 2150 x g at 4°C on Hettich ROTINA35 
centrifuge (Hettich, Germany).
After the discovery of the PS we had controlled 
conditions (analysis 15 minutes and 2 hours after 
phlebotomy, capillary blood smear and blood 
smear from venous blood) of blood samples ma-
nipulation.
While the patient was admitted to the emergency 
room, blood count, ESR, CRP and other biochemi-
cal analysis were made within an hour.
Results
Table 1 presents the results of biochemical param-
eters during hospitalization, Table 2 shows labora-
tory values of urine analysis during the hospitaliza-
tion, while Table 3 indicate values of hematology 
parameters during and after hospitalization and 
Table 4 serum electrophoresis, respectively.
The results show a high concentration of CRP and 
bilirubin on the 1st day of hospitalization (Table 1), 
pathological urine constituents at 1st day (Table 2) 
as well as leukocytosis, mild thrombocytopenia 
(Plt = 129 x109/L) and high sedimentation rate (Ta-
ble 3), all probably due to bacterial infection.
Intravenous antibiotic therapy was initiated after 
the patient was admitted to the hospital. Symp-
toms of inflammation, WBC count and CRP  con-
centration have decreased after 3 days of hospital-
ization, as a sign of successful antibacterial treat-
ment. Biochemical tests - CRP, AST, ALT, ALP, GGT 
and bilirubin (Table 1), urinalysis (Table 2), CBC and 
sedimentation rate (Table 3) were within the nor-
mal range on the 9th (last) day of hospitalization 
and the patient was discharged from the hospital.
On the 1st and 3rd day of hospitalization blood 
smears were not performed by microscope, fol-
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  1st day RI MEUS 9th day* RI MEUS
Albumin 2+ 0 10-15 0 0 1-2 leukocytes
Ketone 3+ 0 leukocytes, 0 0
Urobilinogen 1+ 0 6-8 erithrocytes, 0 0
Leukocytes 3+ 0 many bacteria 0 0
Erythrocytes 4+ 0 0 0
Nitrites pos(+) neg(-) neg(-) neg(-)
Blood culture sterile
Urine culture E.coli > 106 + K. pneumonia = 104
MEUS - Microscopic examination of urine sediment; RI - reference interval.
* Patient was discharged on 9th day.
Table 2. Laboratory values of urine analysis during hospitalization.
1st day 3rd day 9th day* 23 day** Reference interval
WBC (x 109/L) 12.3 6.3 7.9 8.7 3.4-9.7
RBC (x 1012/L) 4.76 4.37 4.33 4.67 3.86-5.08
HB (g/L) 140 127 124 137 119-157
HCT (L/L) 0.419 0.382 0.379 0.408 0.356-0.470
MCV (fL) 88.0 87.3 87.6 87.4 83.0-97.2
MCH (pg) 29.4 29.0 28.7 29.4 27.4-33.9
MCHC (g/L) 334 332 328 336 320-345
PLT K3EDTA (x 109/L)* 129 132 232 160 158-424
MPV (fL) 10.4 10.1 9.4 9.6 6.8-10.4
PLT K3EDTA (x 109/L)# - - - 156 158-424
MPV (fL) - - - 9.9 6.8-10.4
PLT Na-citrate (x 109/L)* - - - 136 158-424
MPV (fL) - - - 8.7 6.8-10.4
PLT Na-citrate (x 109/L)# - - - 130 158-424
MPV (fL) - - - 8.7 6.8-10.4
PLT Li-heparin (x 109/L)* - - - 133 158-424
MPV (fL) - - - 9.3 6.8-10.4
PLT Li-heparin (x 109/L)# - - - 108 158-424
MPV (fL) - - - 9.4 6.8-10.4
ESR mm/3.6 ks 58 - 52 - 5-28
WBC - white blood cells; RBC - red blood cells; HB - hemoglobin; HCT - hematocrit; MCV - mean corpuscular volume; MCH - mean 
corpuscular hemoglobin; MCHC - mean corpuscular hemoglobin concentration; PLT - platelet; MPV - mean platelet volume; ESR - 
erythrocyte sedimentation rate test.
* blood analysis 15 minutes after venous blood sampling
# blood analysis 2 hours after venous blood sampling
- blood analysis wasn’t done
* Patient was discharged on 9th day.
** Control visit
Table 3. Laboratory values of hematology parameters during and after hospitalization. 
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Protein fractions 9th dayRel %
Reference 
interval %
Albumin 52.5 59.8-72.4
α1-globulins 4.1 1.0-3.2
α2-globulins 17.2 7.4-12.6
β-globulins 10.5 7.5-12.9
γ-globulins 15.7 8.0-15.8
weak peak seen in gamma fraction
total proteins g/L 72 66-81
Table 4. Laboratory values of serum proteins during hospital-
ization. 
lowing the routine policy in our laboratory and in-
ternational recommendations (20). Longitudinal 
follow-up of our patient on the 9th day revealed 
that patient didn’t have any microscopic differen-
tial blood count but significant increase in platelet 
count and a microscopic, differential blood count 
was made as per internal rules of the laboratory 
(Table 3). Platelet satellitism was discovered after 
the analysis of blood slides, after which we 
searched for blood smears from 1st and 3rd day, 
but only 3rd day smear was found (Figure 1).
Since the patient had been discharged from the 
hospital on the 9th day, the same day that PS was 
found, there was no possibility of taking a capillary 
blood sample nor for using other anticoagulant 
for determining complete blood count, but serum 
protein analysis (protein electrophoresis) was re-
quested. Serum protein electrophoresis (Table 4) 
showed hipoalbuminemia, increased alpha1- and 
alpha2-globulins component which could be the 
consequence of acute-phase reaction. Due to the 
weak peak in gamma fraction and high ESR, the 
patient is under further, additional observation. 
Three weeks after discharge the patient came to 
the hospital for a follow-up visit (Table 3), during 
which satellitism was repeatedly observed after a 
blood smear examination (Figure 2). 
Figure 1 shows smears made of blood sample with 
K3EDTA as anticoagulant, 3rd and 9th day of hospi-
talization and 23 days after hospitalization and is 
obviously that all presents PS. Figure 2 and Figure 
Figure 1. Blood smear (K3EDTA) A: 3rd day, B: 9th day of hospi-
talization and C: 23 days after hospitalization.
3 showed that only blood smears with EDTA as an 
anticoagulant, had PS while blood smears with cit-
rate have no satellitism.
A
B
C
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Figure 2. Blood smear 23 days after hospitalization - 15 min af-
ter blood sampling (A: K3EDTA, B: Na-citrate, C: Li-heparin).
Figure 3. Blood smear 23 days after hospitalization - 120 min 
after blood sampling (A: K3EDTA, B: Na-citrate, C: Li-heparin).
However, 23th days after hospitalization no signifi-
cant differences were observed in the platelet 
count, in samples with different anticoagulant, 
during the period of time from sampling to the 
analysis (15 and 120 minutes). Exception was a 
blood sample with Li-heparin, where platelet 
A A
B B
C C
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count was significantly lower 120 minutes after 
blood sampling (Table 3). 
There is a possibility that the platelet count de-
creased because of in vitro thrombocytopenia and 
clusters of platelets induced by heparin (Figure 3). 
Heparin is a widely used anticoagulant. Because of 
its negative charge, it forms complexes with posi-
tively charged platelet factor 4 (PF4) on the plate-
let surface. This can induce anti-PF4/heparin IgG 
antibodies, resulting immune complexes that acti-
vates platelets.
Discussion
Pseudothrombocytopenia in general is a wide-
spread problem, present in a number of diseases, 
and unfortunately sometimes remains undiscov-
ered. Therefore, it is particularly necessary to care-
fully identify any false thrombocytopenia and ex-
clude all possible in vitro interference (21). Accord-
ing to our experience and literature, mischaracter-
ization of the platelet count can lead to serious 
problems in patient’s condition, involving addi-
tional, unnecessary tests, non-invasive and inva-
sive procedures such as bone marrow aspiration 
(22), surgery and blood transfusions (23), which 
can lead to serious life-long consequences for the 
patient, or even fatal outcome. Pseudothrombo-
cytopenia is a well-known and solvable problem, 
unlike a rare phenomenon of platelet satellitism 
which is still fairly unknown among laboratory 
staff and therefore often not even recognized as a 
crucial finding. Cases of platelet satellitism due to 
urinary tract infection have been already reported 
in the literature (2,15) and observed in patients 
with vasculitis, lupus (12) and mantle cell lympho-
ma (13), marginal zone B-cell lymphoma (9,17), he-
patocelular carcinoma (24), chronic lymphocytic 
leukemia (25), thrombocytopenic purpura (26), 
squamous cell carcinoma (22), cryofibrinogenemia 
(27), chronic alcoholism (28) as well as in healthy 
individuals (5-7). Cryofibrinogenemia may be pri-
mary (essential) or secondary to other underlying 
disorders, such as carcinoma, infection, vasculitis, 
collagen disease, or associated with cryoglobuli-
nemia (29). Platelet satellitism is not normally asso-
ciated with any platelet dysfunction (30). However, 
due to its low prevalence among the general pop-
ulation, insufficiently clarified mechanism and un-
known causes, this phenomenon requires a writ-
ten presentation in each new case.
In the literature we found information about the 
presence of the PS in a patients’ blood during an 
infectious disease but with no further investiga-
tion, sometime after disease treatment, as we have 
done. The 48-year-old woman studied by Payne 
revealed recurrent, acute, urinary infection, and 
pharyngitis and had two predisposing conditions 
that could contribute to her PS, family history of 
cardiovascular disturbances and extremely long 
menstrual periods, which could consume a large 
number of platelets. Payne didn’t say whether the 
patient has been monitored until discharge from 
hospital, when PS and is it disappeared (2). 
Kopčinović and Pavić reported a case of 91-year-old 
woman with left femoral fracture, who developed 
myocardial infarction, received transfusion thera-
py and developed urinary infection. The patient 
showed PS in blood smear which disappeared two 
days later and it was no longer present in the 
blood smear for the rest of hospitalization (15).
PS was also observed in healthy individuals. Ja-
meel et al. was explaining a case of 55-year-old 
male having apparently good health, Morelli et al. 
observed 35-year-old women who have had a re-
peated mild thromocytopenia during routine 
check-up, but without any further explanation of 
this case as well as Hernández-Chavarría and Vega 
with a 21-year-old man (5-7). However, since health 
status was not appropriately explained in neither 
of the above mentioned cases, it is rather ques-
tionable whether the patients have indeed been 
healthy or have suffered from some unknown un-
derlying disease.
In case of our patient the reasons for PS have not 
been completely understood. This case presents 
phenomenon in patient with an infectious disease 
and it still remained 17 days after curing the dis-
ease in samples with EDTA along with the in vitro 
thrombocytopenia and presence of platelet clus-
ters induced by heparin.
The question arises whether our case is the phe-
nomenon of a healthy individual, impact of infec-
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tion or is there some third explanation? Unfortu-
nately we can only speculate about the real causes 
behind this phenomenon, exposing the facts and 
conditions under which it was found, with certain 
limitation of the study. Given the fact that our pa-
tient had a chronic disease, high concentration of 
gamma–globulin and weak peak seen in gamma 
fraction, we were not able to speculate about the 
possible true cause-effect relationship responsible 
for PS.
Each new case has to be reported in order to raise 
awareness of laboratory staff of the existence of PS 
and thus contribute to the resolution of the causes 
of this phenomenon and also importance of pseu-
dothrombocytopenia detection, in general. Possi-
ble explanation for our case could involve immu-
nological mechanism that includes formation of 
antibodies and subsequent binding of platelets to 
target neutrophil membranes and vice versa. The 
trigger is not known especially because PS didn’t 
disappear even after the patient condition im-
proved.
To our knowledge this is the second case of plate-
let satellitism ever described in Croatia. Although 
in the absence of lack of ability to generalize, any 
new information can improve global understand-
ing of possible mechanisms and nature of its ap-
pearance, in people suffering from various diseas-
es as well as in healthy individuals. 
Potential conflict of interest
None declared.
References
1. Field EJ, MacLeod I. Platelet adherence to polymor-
phs. Br Med J 1963;2:388-389. http://dx.doi.org/10.1136/
bmj.2.5353.388-b.
2. Payne CM. Platelet Satellitism: An Ultrastructural Study. 
Am J Pathol 1981;103:116-28.
3. Bobba RK, Doll DC. Platelet satellitism as a cause of spurio-
us thrombocytopenia. Blood 2012;119:4100. http://dx.doi.
org/10.1182/blood-2011-08-369173.
4. Kasprzycka E, Zak J, Ratomski K, Wysocka J, Hryniewicz K. 
Platelet satellitism. Wiad Lek 2006;59:557-9.
5. Jameel T, Mehmood K, Tanveer I, Saadia A. Platelet Satelli-
tism: An infrequent cause of spurious thrombocytopenia. 
Annals of KEMU 2011;17:91-3.
6. Morselli M, Longo G, Bonacorsi G, Potenza L, Emilia G, Tore-
lli G. Anticoagulant pseudothrombocytopenia with plate-
let satellitism. Haematologica 1999;84:655.
7. Hernández-Chavarría F, Vega B. Is Platelet satellitism an in-
frequent phenomenon? Rev Biomed 2004;15:137-8.
8. Español I, Muñiz-Diaz E, Domingo-Clarós A. The irreplace-
able image: Platelet satellitism to granulated lymphocytes. 
Haematologica 2000;85:1322.
9. Montague N, Blackwelder P, Alsayegh H, Ochoa R, Vial X, 
Byrne GE. Platelet satellitism and dual surface immunoglo-
bulin light-chain expression in circulating splenic marginal 
zone lymphoma cells. Ann Diagn Pathol 2013;17:117-22. 
http://dx.doi.org/10.1016/j.anndiagpath.2011.06.001.
10. Yoon KH. A case of platelet satellitism with platelet pha-
gocytosis by neutrophils and platelet-neutrophil agglu-
tination. Lab Med Online 2013;3:259-63. http://dx.doi.
org/10.3343/lmo.2013.3.4.259.
11. Christopoulos C, Mattock C. Platelet satellitism and alpha 
granule proteins. J Clin Pathol 1991;44:788-9. http://dx.doi.
org/10.1136/jcp.44.9.788.
12. Lazo-Langner A, Piedras J, Romero-Lagarza P, Lome-Mal-
donado C, Sánchez-Guerrero J, López-Karpovitch X. Pla-
telet satellitism, spurious neutropenia, and cutaneo-
us vasculitis: casual or causal association? Am J Hematol 
2002;70:246-9. http://dx.doi.org/10.1002/ajh.10141.
13. Cesca C, Ben-Ezra J, Riley RS. Platelet satellitism as presen-
ting finding in mantle cell lymphoma. Am J Clin Pathol 
2001;115:567-70. http://dx.doi.org/10.1309/MMYE-VAVP-
54LJ-JJ23.
14. Chakrabarti I. Platelet Satellitism: A Rare, Interesting, 
In Vitro Phenomenon. Indian J Hematol Blood Transfus 
2014;30:213-4. http://dx.doi.org/10.1007/s12288-013-0247-2.
15. Kopcinovic LM, Pavic M. Platelet satellitism in a trauma pa-
tient. Biochem Med (Zagreb) 2012;22:130-3. http://dx.doi.
org/10.11613/BM.2012.016.
16. Bizarro N, Goldshmeding R, Borne AE. Platelet Satellitism is 
Fc Gamma RIII (CD16) receptor-mediated. Am J Clin Pathol 
1995;103:740-4.
17. Debourgogne A, V Latger-Cannard, K Montagne, F Plénat, 
T Lecompte. A marginal zone-B cell lymphoma revea-
led by platelet satellitism and lympho-agglutination phe-
nomenon around atypical lymphocytes. Ann Biol Clin 
2007;65:287-90. 
18. Sakurai S, Tanigawa T, Nakahara K, Takenaka K, Ohkubo A. 
Effects of kanamycin on platelet satellitism and leukocyte 
adhesion phenomena. Rinsho Byori 1995;43:142-8.
Biochemia Medica 2015;25(2):285–94  http://dx.doi.org/10.11613/BM.2015.030 
294
Vidranski V. et al. Platelet satellitism 
19. Mousa SA, Bozarth JM, Forsythe MS, Slee A. Differential an-
tiplatelet efﬁcacy for various GPIIb/IIIa antagonists: Role of 
plasma calcium levels. Cardiovasc Res 2000;47:819. http://
dx.doi.org/10.1016/S0008-6363(00)00150-4.
20. Barnes PW, McFadden SL, Machin SJ, Simson E. The inter-
national consensus group for hematology review: sugge-
sted criteria for action following automated CBC and WBC 
differential analysis.Lab Hematol 2005;11:83-90. http://
dx.doi.org/10.1532/LH96.05019.
21. Mourad S de C, Takihi IY, Sandes AF. Platelet satellitism. 
Rev Bras Hematol Hemoter 2013;35:293. http://dx.doi.
org/10.5581/1516-8484.20130060.
22. Padayatty J, Grigoropoulos N, Gilligan D, Follows GA. Pla-
telet satellitism. Eur J Haematol 2010;84:366. http://dx.doi.
org/10.1111/j.1600-0609.2009.01386.x.
23. Wilkes NJ, Smith NA, Mallet SV. Anticoagulant-induced Pse-
udothrombocytopenia in a Patient Presenting with Coro-
nary Artery Bypass Grafting. Brit J of Anesthet 2000;84:640-
2. http://dx.doi.org/10.1093/bja/84.5.640.
24. Yoshikawa T, Nakanishi K, Maruta T, Takenaka D, Hirota S, 
Matsumoto S, et al. Anticoagulant-induced pseudothrom-
bocytopenia occurring after transcatheter arterial em-
bolization for hepatocellular carcinoma. Jpn J Clin Oncol 
2006;36:527–53. http://dx.doi.org/10.1093/jjco/hyl054.
25. Deol I, Hernandez AM,  Pierre RV. Ethylenediamine tetraa-
cetic acid-associated leukoagglutination. Am J Clin Pathol 
1995;103:338-40.
26. White LA Jr, Brubaker LH, Aster RH, Henry PH, Adelstein 
EH. Platelet satellitism and phagocytosis by neutrophils: 
association with antiplatelet antibodies and lymphoma. 
Am J Hematol 1978;4:313-23. http://dx.doi.org/10.1002/
ajh.2830040403.
27. McGregor DH, Davis JW, Liu PI, Gates E, Poindexter AR. 
Platelet satellitism: experimental studies. Lab Invest 
1980;42:343-55.
28. Dauendorffer JN, Latger-Cannard V, Lesesvre JF, Lecomp-
te T. Platelets satellitism with polynuclear neutrophils. Ann 
Biol Clin 2000;58:91-3. 
29. Michaud M, Pourrat J. Cryofibrinogenemia. J Clin Rhe-
umatol 2013;19:142-8. http://dx.doi.org/10.1097/RHU. 
0b013e318289e06e.
30. Kjeldsberg CR, Swanson J. Platelet Satellitism. Blood 1974; 
43:831-6.
